earnings
CR
NASDAQ · CRON
Cronos Group Inc.
Healthcare · Drug Manufacturers - Specialty & Generic
$3.31
Up+$0.09 (+2.80%)
Updated Aug 22, 2026, 1:48 PM
SID Score
5.6/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.09B
- P/E ratio
- 59.51
- Dividend yield
- 0.00%
- 52-week range
- $2.38 – $3.31
- Volume
- 1.31M
- Avg. volume
- 1.99M
Price performance
CRON price history
1M range · 21 trading sessions · Daily adjusted prices
CRON closed at $3.31 after 21 trading sessions, up 17.79% for the selected period.
- Last close
- $3.31
- Period change
- +17.79%
- Period low
- $2.72
- Period high
- $3.31
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Aug 21, 2026 | $3.23 | $3.32 | $3.22 | $3.31 | 1.31M |
| Aug 20, 2026 | $3.275 | $3.299 | $3.21 | $3.22 | 998.13K |
| Aug 19, 2026 | $3.21 | $3.30 | $3.21 | $3.29 | 1.38M |
| Aug 18, 2026 | $3.14 | $3.24 | $3.13 | $3.21 | 1.05M |
| Aug 17, 2026 | $3.14 | $3.18 | $3.12 | $3.15 | 1.33M |
| Aug 14, 2026 | $3.15 | $3.16 | $3.045 | $3.14 | 1.03M |
| Aug 13, 2026 | $3.17 | $3.31 | $3.15 | $3.16 | 1.51M |
| Aug 12, 2026 | $3.06 | $3.175 | $3.04 | $3.17 | 2.05M |
| Aug 11, 2026 | $3.04 | $3.09 | $3.01 | $3.08 | 1.21M |
| Aug 10, 2026 | $3.08 | $3.11 | $2.99 | $3.00 | 1.66M |
| Aug 7, 2026 | $3.13 | $3.17 | $3.065 | $3.10 | 2.09M |
| Aug 6, 2026 | $3.02 | $3.12 | $2.902 | $3.07 | 5.7M |
| Aug 5, 2026 | $2.81 | $2.81 | $2.685 | $2.72 | 1.72M |
| Aug 4, 2026 | $2.84 | $2.865 | $2.79 | $2.81 | 1.4M |
| Aug 3, 2026 | $2.84 | $2.89 | $2.82 | $2.83 | 901.67K |
| Jul 31, 2026 | $2.89 | $2.90 | $2.81 | $2.83 | 728.46K |
| Jul 30, 2026 | $2.87 | $2.91 | $2.855 | $2.89 | 822.81K |
| Jul 29, 2026 | $2.85 | $2.879 | $2.825 | $2.86 | 1.06M |
| Jul 28, 2026 | $2.85 | $2.87 | $2.83 | $2.85 | 828.16K |
| Jul 27, 2026 | $2.82 | $2.88 | $2.76 | $2.86 | 1.07M |
| Jul 24, 2026 | $2.75 | $2.84 | $2.74 | $2.81 | 1.22M |
Latest CRON news
The latest Smart Investors Daily articles mentioning CRON.
Stock researchCompany · Financials
Loading stock research…